Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label INR. Show all posts
Showing posts with label INR. Show all posts

Friday, February 5, 2021

INR blood monitoring

 When I was on warfarin I had to have weekly blood draws which was only possible since my ex was not employed. A much better solution would be something like the Libre blood glucose monitoring system, but using Needle free blood draws or microneedles to monitor INR for warfarin use instead of having to come in for blood draws? We'll never know with our incompetent stroke leadership.

A great stroke association could build this and sell them to the millions of stroke survivors but we have NO STROKE LEADERSHIP. 


 

Tuesday, December 24, 2019

NUS researchers develop microsensor implants smaller than a pencil tip for round-the-clock health monitoring

And if we had even two neurons to rub together in our fucking failures of stroke associations they would recognize and create innovation on top of this to measure INR and the correct level of blood clotting when taking aspirin. To send an emergency notification that the levels in the blood aren't correct and need immediate attention.  But nothing will occur.  It is not their job to solve stroke, I don't know what fucking purpose they do have but it is not to solve stroke and help survivors recover.

NUS researchers develop microsensor implants smaller than a pencil tip forround-the-clock health monitoring

Current efforts to make these microsensors small have been largely hampered by technology limitations. These sensors are too small to be powered by a battery, so they require a sensor reader to be placed near them to constantly detect signals such as chemical or pressure changes using magnetic fields. For a reader to make sense of the signals, the sensor must be large enough to create a strong signal in the reader. So far, researchers have not been able to create viable microsensors below 1 millimetre.

The NUS team from the Department of Electrical and Computer Engineering at the NUS Faculty of Engineering and the NUS Institute for Health Innovation and Technology, led by Assistant Professor John Ho, developed a new way of measuring the signal, by calibrating the wireless reader to work at an exceptional point. This is a special state where the reader becomes extremely sensitive to nearby objects. The result is that the new reader is so sensitive—three times more sensitive than existing readers—that it can even read the tiny signals emitted by the sub-millimetre microsensors.
The team developed a working prototype of the reader that can read a microsensor that is 0.9 millimetres in diameter while implanted underneath the skin using a syringe. In lab experiments, the reader was able to monitor the rate of breathing and heart rate by detecting subtle movements of the battery-free microsensor.
It took two years of research by the team, from February 2017 to January 2019, to develop this innovative microsensor. The team’s achievement was published in August 2019 in the scientific journal Nature Electronics.
“We hope that our breakthrough will be a trailblazer for the future of minimally invasive health monitoring solutions where patients are immediately alerted whenever their physiological conditions such as heart rate and blood glucose cross a critical threshold,” said Asst Prof Ho.
“Now that we have proven the viability of our reader, the next step is to develop a suite of passive (battery-free) microsensors that can monitor various physiological parameters such as glucose, bioelectrical activity and blood chemistry,” he added.


Tuesday, July 23, 2019

Probable Interaction Between Warfarin and Inhaled and Oral Administration of Cannabis

Since your doctor will never recommend cannabis and you will never listen to me, this problem will never occur in you. It might occur in me but that will be my choice.  

My 13 reasons for marijuana use post-stroke.  

Don't follow me, I'm not medically trained and I don't have a Dr. in front of my name.

Probable Interaction Between Warfarin and Inhaled and Oral Administration of Cannabis

First Published July 18, 2019 Case Report
To report a probable interaction between warfarin and edible cannabis that resulted in an elevated international normalized ratio (INR) without bleeding complications.
A 35-year-old Middle Eastern male on warfarin long term with an INR goal of 2.5 (accepted range: 2.0-3.0). The patient has generally been stable on warfarin 10 mg daily from 2010 to 2018, until INR suddenly increased to 7.2 following 1 month of edible cannabis ingestion and cannabis smoking. Patient denied any signs and symptoms of bleeding. No other reasonable causes of the elevation in INR were apparent. The patient was advised to hold 2 doses of warfarin and discontinue cannabis use. The INR dropped below 4 upon discontinuation of cannabis with dose adjustments to warfarin.
The elevation in INR can be explained by the inhibition of CYP2C9 by cannabis use causing decreased metabolism of warfarin. The interaction between warfarin and cannabis was determined to be probable using the Horn Drug Interaction Probability Scale.
There are no previous reports of interactions between edible cannabis and warfarin, with very few case reports describing the interaction with other forms of cannabis. Close monitoring of INR in patients with concomitant cannabis is recommended for proper warfarin management.

Thursday, October 12, 2017

Smart Tattoo Monitors Health

Could this be used along Needle free blood draws or microneedles to monitor INR for warfarin use instead of having to come in for blood draws? We'll never know with our incompetent stroke leadership. 

Smart Tattoo Monitors Health 


Checking vital health statistics may someday be as simple as shinning a light on a tattoo.
A group of researchers from Harvard Medical School (HMS) and the Massachusetts Institute of Technology (MIT) have developed a smart tattoo ink that changes color to signal changes in various biomarkers, including if an athlete is dehydrated or if a diabetic’s blood sugar rises.
The researchers paired biosensitive inks with traditional tattoo artistry as a way to overcome some of the limitations of biomedical monitoring devices that currently do not seamlessly integrate with the body.
“We were thinking: New technologies, what is the next generation after wearables?” Ali Yetisen, who is a Tosteson postdoctoral fellow at HMS and Massachusetts General Hospital, said in a statement. “And so we came up with the idea that we could incorporate biosensors in the skin.”
The stabilizing ink does not fade or diffuse into surrounding tissue and only changes color according to the chemistry of the body’s interstitial fluid—which can be used as a surrogate for constituents of the blood.
The researchers developed a pair of inks that signify glucose concentration and sodium concentration.
The first ink will change from green to brown as glucose concentration increases, while the second ink grows a more intense green color when viewed under a blue light as sodium concentration rises, an indication of dehydration.
To test the inks, the researchers tattooed segments of pig skin and found the changes in color or intensity in response to different biomarkers.
The next step will be to test the tattoos with other diseases and biomarkers.
The researchers said a long-lasting tattoo could be used to monitor chronic conditions or a temporary design could be used for shorter-duration monitoring.
The ink can also be invisible and only viewable under certain kinds of light that may be available through a smartphone application.    

Saturday, January 7, 2017

Skin patch with microneedles proves effective alternative to injections

With just a bit of innovation this could be used to monitor INR levels and not need to go to the clinic to get a blood draw. A great stroke association would direct some of their employees to solve this rather than waiting for SOMEONE ELSE TO SOLVE THE PROBLEM.  A few patents like this could provide a continuing stream of money to fund research. But that will never occur with the fucking failures of stroke associations we have now.
https://www.mdlinx.com/internal-medicine/top-medical-news/article/2017/01/04/5

KTH Royal Institute of Technology News
It’s only a matter of time before drugs are administered via patches with painless microneedles instead of unpleasant injections. But designers need to balance the need for flexible, comfortable–to–wear material with effective microneedle penetration of the skin. Researchers from KTH Royal Institute of Technology in Stockholm say they may have cracked the problem.

In a study the research team from KTH reports a successful test of its microneedle patch, which combines stainless steel needles embedded in a soft polymer base – the first such combination believed to be scientifically studied. The soft material makes it comfortable to wear, while the stiff needles ensure reliable skin penetration.

Unlike epidermal patches, microneedles penetrate the upper layer of the skin, just enough to avoid touching the nerves. This enables delivery of drugs, extraction of physiological signals for fitness monitoring devices, extracting body fluids for real–time monitoring of glucose, pH level and other diagnostic markers, as well as skin treatments in cosmetics and bioelectric treatments.

Frank Niklaus, professor of micro and nanofabrication at KTH, says that practically all microneedle arrays being tested today are “monoliths”, that is, the needles and their supporting base are made of the same – often hard and stiff – material. While that allows the microneedles to penetrate the skin, they are uncomfortable to wear. On the other hand, if the whole array is made from softer materials, they may fit more comfortably, but soft needles are less reliable for penetrating the skin.

“To the best of our knowledge, flexible and stretchable patches with arrays of sharp and stiff microneedles have not been demonstrated to date,” he says.

They actually tested two variations of their concept, one which was stretchable and slightly more flexible than the other. The more flexible patch, which has a base of molded thiol–ene–epoxy–based thermoset film, conformed well to deformations of the skin surface and each of the 50 needles penetrated the skin during a 30 minute test.

A successful microneedle product could have major implications for health care delivery. “The chronically ill would not have to take daily injections,” says co–author Niclas Roxhed, who is research leader at the Department of Micro and Nano Systems at KTH.

In addition to addressing people’s reluctance to take painful shots, microneedles also offer a hygiene benefit. The World Health Organization estimates that about 1.3 million people die worldwide each year due to improper handling of needles.

“Since the patch does not enter the bloodstream, there is less risk of spreading infections,” Roxhed says.

The report, Flexible and Stretchable Microneedle Patches with Integrated Rigid Stainless Steel Microneedles for Transdermal Biointerfacing, was published in the journal PLOS ONE.

Wednesday, August 3, 2016

E-Skin Patch Accurately Tracks Blood-Alcohol Levels

What else could it track with some innovative thinking from our great stroke association? INR testing? Blood pressure? Blood oxygen levels? Stroke in progress? 

E-Skin Patch Accurately Tracks Blood-Alcohol Levels



A new type of temporary tattoo could potentially prevent drunk driving accidents in the future.
Engineers from the University of California, San Diego designed an electronic wearable patch that can measure an individual’s blood alcohol level through sensible sweat, the visible form of perspiration that could provide a better real-time indicator of a person’s blood alcohol concentration.
The invention is comprised of screen-printed electrodes, a miniature hydrogel patch housing a sweat-inducing drug called pilocarpine, as well as a flexible electronic circuit board that simultaneously powers the tattoo and enables wireless communication with a mobile device.
“Lots of accidents on the road are caused by drunk driving. This technology provides an accurate, convenient and quick way to monitor alcohol consumption to help prevent people from driving while intoxicated,” said nanoengineering professor Joseph Wang, one of the co-leaders of this experiment, in a statement.
Please follow R&D Magazine on LinkedIn
It was tested on nine healthy volunteers where it was attached to their arms after drinking either a bottle of beer or a glass of red wine, according to the university’s announcement.
The process begins when the tattoo discharges the pilocarpine to make the wearer sweat. An electrode coated in the alcohol oxidase enzyme will react by generating hydrogen peroxide upon coming into contact with the individual’s perspiration.
Hydrogen peroxide can be detected electrochemically so that information is transformed into electrical signals sent wirelessly to a mobile device through Bluetooth, per the university’s press release.
It took about 15 minutes for the tattoo to deliver results. The accuracy of the results remained intact after numerous attempts at bending and shaking the tattoo emphasizing read-outs won’t be impaired by movement.
Wang suggested that this technology could eventually be built into a car’s alcohol ignition locks, but his team’s next steps will be designing a device that may be able to monitor alcohol levels for a full 24 hours.
Another organization is developing an alternative method for tracking blood alcohol levels with a slight tweak.
San, Francisco-based BACtrack won a $200,000 grand prize in May for its prototype wrist monitor named BACtrack Skyn. This device measures the ethanol seeping through a person’s skin in order to determine how much they’ve had to drink, but takes 45 minutes to completely analyze the information it’s given.

Tuesday, July 19, 2016

Fluctuations in “bad” cholesterol may be linked to worse brain health

How would your doctor even know if this is happening to you? While INR testing does not necessarily require fasting anymore, I'm sure frequent blood draws for this would not be covered by insurance. Unless the needle free blood draws come into practice soon.
http://www.alphagalileo.org/ViewItem.aspx?ItemId=166067&CultureCode=en
Greater fluctuations in “bad” cholesterol levels may be linked to worse cognitive function in elderly adults, according to new research in the American Heart Association’s journal Circulation.
In a study of European adults age 70 to 82 years old, researchers found that greater fluctuations in low-density lipoprotein cholesterol (LDL), or “bad” cholesterol, are associated with lower cognitive performance.
For example, study participants with the highest LDL cholesterol variability took 2.7 seconds longer on average to finish a cognitive test to name ink colors of color words written in different ink (for example, the word blue written in red ink), compared to individuals with the lowest variability.
“While this might seem like a small effect, it is significant at a population level,” said Roelof Smit, M.D., lead study author and a Ph.D. student at Leiden University Medical Center in Leiden, the Netherlands.
The link between variability and declining cognitive function was found regardless of average bad cholesterol levels or use of cholesterol-lowering statin drugs.
In addition, greater fluctuations in bad cholesterol were associated with lower brain blood flow and greater white matter hyperintensity load - which has been linked to endothelialdysfunction.
These results show LDL cholesterol variability may be important to neurocognitive function, Smit said.
“Our findings suggest for the first time that it’s not just the average level of your LDL-cholesterol that is related to brain health, but also how much your levels vary from one measurement to another,” Smit said.
Measurements fluctuate because of diet, exercise, frequency of cholesterol-lowering statins and other factors, he said. However, these fluctuations might also reflect an increasingly impaired homeostasis; for example, due to age or underlying disease, added J.Wouter Jukema, M.D., Ph.D., senior author of the study and professor of Cardiology at the Leiden University Medical Center.
The research involved 4,428 participants from Scotland, Ireland and the Netherlands in the PROspective Study of Pravastatin in the Elderly at Risk. PROSPER participants either had preexisting vascular disease or were at a higher risk for developing the condition because of histories of hypertension, cigarette smoking or diabetes.
Researchers examined associations between LDL cholesterol variability and four cognitive measures: color-word test for selective attention, letter-digit coding to assess information processing speed and picture-word learning to test verbal memory in two ways – immediate recall and delayed recall after 20 minutes.
Although the research population was European, the results may be applicable to Americans as their lifestyle patterns predispose them to the same set of clinical outcomes, Smit said. But the results cannot be extrapolated directly to the general U.S. population because the study participants were older adults at high risk for vascular disease.
“These results add an important puzzle piece to the emerging evidence that vascular risk factors are closely related to brain health,” Smit said.  “Our study is just the first exciting step. Further studies are needed to examine whether these findings could truly influence clinical practice.”
http://newsroom.heart.org/news/fluctuations-in-bad-cholesterol-may-be-linked-to-worse-brain-health?preview=c778cef4bfb05954aef5021158d0a591

Tuesday, May 31, 2016

Velano Vascular needle-free blood draw device

How long before your hospital get this for those damned INR draws? Will you be able to sleep thru the 7am blood draws with this?
http://www.mdlinx.com/internal-medicine/product-center/medical-device-description.cfm/8922/?featured=no 

New device reduces risks, anxiety associated with blood draws

Velano Vascular —
Velano Vascular needle-free blood draw device
The FDA has granted clearance to a modified version of Velano Vascular’s novel, needle-free blood draw device, which is designed to reduce blood draw-related discomfort and anxiety for hospital inpatients, provide a safer work environment for healthcare providers, and standardize today’s fragmented approaches to inpatient blood draws. This second FDA clearance of the device includes two modifications designed to enhance the product’s usability for inpatient blood draws, one of the most common medical procedures performed today: The addition of a clamp for use with syringe draws, a frequent practice in pediatric patients, and a refinement to the Indication for Use (IFU). The Velano device is attached to a peripheral IV catheter to draw blood directly into a vacuum tube or a syringe; the revised IFU removes a limitation in the earlier clearance that specified when the device could be used with in-dwelling peripheral IV catheters. Roughly 760 inpatient blood draws are conducted every minute in the United States alone. Despite their ubiquity, blood draws create tremendous disruption for patients and clinicians alike, and are associated with significant direct and indirect costs. Twenty-eight percent of adult venipunctures and 44 percent of pediatric venipunctures require more than one stick to successfully draw blood, and around 10 percent of children aged 3 to 10 years old must be physically restrained to endure a needle-based blood draw. Published data suggest that U.S. healthcare professionals endure an average of 200 needle-related injuries each day. Aside from the significant physical and emotional toll of these injuries and any related seroconversion, studies suggest that accidental needle sticks cost hospitals upwards of $50 million per year.


Tuesday, April 26, 2016

Vein Illuminator Technology for drawing blood

This wuld be great for all those blood draws in testing INR.
https://www.facebook.com/UNILADTech/videos/1709409186003462/?fref=nf
Drawing blood from someone has never been easier with this new technology.

Wednesday, November 25, 2015

Tech Tats: The Future of Wearables?

I could easily see this being used for stroke survivors, by adding a nano needle patch you should be able to monitor INR and cholesterol levels. A great stroke association would have hundreds of patents supplying money to be used in research. That's if we had any stroke leadership at all. Which we don't.

Tech Tats: The Future of Wearables?

A forlorn girl sits at the bottom of a staircase in her household. An adult comes by with a small plastic case, opening it to reveal a rectangle sheet. The adult applies the sheet to the girl’s arm and holds a cloth over it. The cloth is pulled away and a small circuit board-like array with glowing green dots is stuck to the girl’s deltoid. The adult pulls out her smartphone, where the girl’s vitals are displayed.  
“Rather than going to the doctor once a year to get your physical, this Tech Tattoo can be something that you just put on your body once a year and it monitors everything that they would do in a physical and sends that to your doctor, and if there’s an issue, they could call you,” said Eric Schneider, a creative technologist with Chaotic Moon, the developer of Tech Tats, in a video.
“It can look at early signs of fever, your vital signs, heartrate, everything that it needs to look at to notify you that you’re getting sick, or your child is getting sick.”
According to Vice’s Motherboard, the tattoo uses electroconductive paint to transfer data from temperature sensors to an ATiny85 microcontroller.
While the focus is currently on the medical field, Schneider floats the idea of using the Tech Tat as a way to revolutionize the banking industry. Rather than carrying wallets around, credit cards and identification information can be stored right on one’s skin.
Speaking with TechCrunch, Chaotic Moon CEO Ben Lamm said, “The future of wearables is biowearables.” He added that the company is in talks with partners to bring Tech Tats to market.
Chaotic Moon is a software company based in Austin, Texas.

Thursday, May 14, 2015

DARPA Takes A Stab At Needle-Free Blood Draws

This would be so great for our INR testing needs. Then I wouldn't have to be woken up at 7am in the hospital for the vampires to take a sample of my blood. But I bet your hospital will not be using this for 40 years.
http://www.forbes.com/sites/robertszczerba/2015/05/13/darpa-takes-a-stab-at-needle-free-blood-draws/

Wednesday, July 30, 2014

Smart tattoo sensors

Right now this seems limited but with any decent innovative thinking at all we could use this for stroke. But do you really think the ASA or NSA will take advantage of this to help stroke survivors?
1. Monitor INR levels because of warfarin use.
2. biofeedback on muscle movement.
3. Monitor brain functions after first stroke, send notices of problems to your smartphone and have it call 911.


“Smart Tattoo” Glucose Biosensors and Effect of Coencapsulated Anti-Inflammatory Agents

----------------------------------------------------------------------

Motorola patents e-tattoo that can read your thoughts by listening to unvocalized words in your throat
Would this be useful for aphasia?
 ----------------------------------------------------------------------

‘Smart tattoo’ may replace finger prick for diabetics

INR maybe? 


----------------------------------------------------------------------

Sensors with a smile: The smart 'tattoo' that can measure how tired you are

And your doctor could use this to monitor your fatigue and figure out exactly what causes it. Or is your doctor not willing to solve any of your stroke problems?

----------------------------------------------------------------------

Smart skin electronic tattoos the next leap in health tech

This membrane-like patch can be used to monitor body temperature, heartbeat, brain waves, aid muscle movement, and even help heal wounds

 

 


 


 

Saturday, March 16, 2013

Wear Your Doctor

The inventors at a Great stroke association would tackle creating  an INR tracking device for your warfarin levels so you wouldn't need to go for a blood draw every week. Wearing a electronic bandaid wouldn't be so bad unless you are paranoid about government monitoring. .
http://ideas.time.com/2013/03/14/10-big-ideas/slide/wear-your-doctor/

Friday, November 16, 2012

A Bayesian Dose-Individualization Method for Warfarin

For you statistical and probability geeks. In case your doctor is not.
http://adisonline.com/pharmacokinetics/Abstract/publishahead/A_Bayesian_Dose_Individualization_Method_for.99925.aspx

Abstract

Background: Warfarin is a difficult drug to dose accurately and safely due to large inter-individual variability in dose requirements. Current dosing strategies appear to be sub-optimal, with reports indicating that patients achieve international normalized ratios (INRs) within the therapeutic range only 40-65 % of the time. The consequences of poor INR control are potentially severe with INRs below 2 carrying an increased risk of clotting while INRs >4 increase the risk of major bleeding events. Bayesian forecasting methods have the potential to improve INR control.
Aims: The aims of this study were to (1) prospectively assess the predictive performance of a Bayesian dosing method for warfarin implemented in TCIWorks; and (2) determine the expected time in the therapeutic range (TTR) of INRs predicted using TCIWorks.
Methods: Patients who were initiating warfarin therapy were prospectively recruited from Dunedin Hospital, Dunedin, New Zealand. Warfarin doses were entered into TCIWorks from the first day of therapy until a stable steady-state INR (INRss) was achieved. The predicted INRss values were determined using the first zero to six serially collected INR observations. Observed and predicted INRss values were compared using measures of bias (mean prediction error [MPE]) and imprecision (root mean square error [RMSE]). The TTR was determined by calculating the percentage of predicted INRss values between 2 and 3 when zero to six serially collected INR observations were available.
Results: A total of 55 patients were recruited between March and November 2011. When no observed INR values were available the resulting INRss predictions were positively biased (MPE 0.52 [95 % CI 0.30, 0.73]); however, this disappeared once observed INR values were entered into TCIWorks. The precision of the predicted INRss values improved dramatically once three or more observed INR values were available (RMSE less than 0.53) compared with no INRs (RMSE 0.96). These results suggest that TCIWorks will be effective at maintaining the INR within the therapeutic INR range (2-3) 65 % of the time when three INR measurements are available and 80 % of the time when six INR measurements are available.
Conclusion: The TCIWorks warfarin dosing method produced accurate and precise INRss predictions. We predict that the method will provide an INR value within the therapeutic range 65-80 % of the time once three or more INR observations are available, making this a useful tool for clinicians and warfarin clinics. Further research to assess the impact of this method on long-term INR control is warranted.

Sunday, August 5, 2012

Warfarin Management International Normalized Ratio Self-Testing and Warfarin Self-Dosing

So it seems self-testing is now possible.
http://circ.ahajournals.org/content/126/5/e52.short
Until recently, most patients taking warfarin (brand name Coumadin) had to visit a laboratory and/or clinic every few weeks for an international normalized ratio (INR) blood test and adjustment of their warfarin dose. It is now possible for a patient to measure his/her INR (self-testing) with a finger-stick drop of blood with use of a small, portable, battery-powered device. Some self-testing patients adjust their dose of warfarin (self-dosing) based on a set of instructions. Even more recently, online systems have been developed to facilitate and improve self-testing and self-dosing. Patients who use self-testing have described it as life changing. A video on the ease and benefits of self-testing by a physician-patient named Dr Michael Schwartz can be viewed on ClotCare at www.clotcare.org/inrselftestingvideo.aspx.

Does Self-Testing Offer Benefits Beyond Ease and Convenience?

Yes. The additional benefits are why Medicare and other insurance companies started paying for self-testing for most patients in March 2008. To understand the other potential benefits, however, one needs some background information. Warfarin is used to prevent blood clots that cause strokes, heart attacks, or other life-threatening conditions. If the dose of warfarin is too small, the INR will be low, and a patient may get a blood clot. If the dose is too large, the INR will be high, and a patient may develop a bleeding problem. In most cases, an INR between 2 and 3 indicates that the warfarin dose is about right. In one large study,1 the risk of stroke caused by a blood clot increased 3 to 4 times when the …

Friday, July 6, 2012

Hemarthrosis in a Patient on Warfarin Receiving Ceftaroline: A Case Report and Brief Review of Cephalosporin Interactions with Warfarin

Another item to talk to your doctor about.
http://www.theannals.com/content/early/2012/07/03/aph.1Q771.abstract

Abstract

OBJECTIVE: To report a possible interaction between warfarin and ceftaroline, resulting in hemarthrosis, and provide readers with an understanding of mechanisms of interaction between cephalosporins and warfarin.
CASE SUMMARY: Ceftaroline was prescribed for an 85-year-old female with a therapeutic international normalized ratio (INR) hospitalized for the treatment of cellulitis. She was subsequently readmitted with shoulder pain and a supra-therapeutic INR. The patient was diagnosed with hemarthrosis, presumably related to elevated INR. Evaluation using the drug interaction probability scale for warfarin and ceftaroline yielded a score consistent with a possible or probable interaction.
DISCUSSION: Cephalosporins may interact with warfarin through a variety of mechanisms, including potentiation of hypoprothrombinemia related to certain side chain groups, inhibition of P-glycoprotein, or alteration of gastrointestinal flora. All mechanisms reported in the medical literature as of April 2012 are briefly examined, but the latter is the most reasonable mechanism for a ceftaroline interaction with warfarin.
CONCLUSIONS: Health care providers should consider closely monitoring patients receiving antibiotics with activity against Enterobacteriaceae and warfarin, even if no direct mechanism of interaction has been reported. Further research regarding a ceftaroline-warfarin interaction is warranted.

Monday, April 9, 2012

Cardio Notes: Coumadin Home Testing Viable

I hated having to get my INR levels tested when I was on warfarin(rat poison). I wonder how long before its available.
http://www.medpagetoday.com/Cardiology/Arrhythmias/32085?utm_source=cardiodaily&utm_medium=email&utm_content=aha&utm_campaign=04-09-12&eun=gd3r&userid=424561&email=oc1dean@yahoo.com&mu_id=5523591

Warfarin Self-Testing Scores Big

Patients on warfarin (Coumadin) who used a self-testing device were able to maintain a high rate of time in target range, a retrospective analysis of the STABLE study found.

Of the nearly 30,000 patients analyzed, the rate of time in target range for those who self-tested weekly was 73%, while the overall rate, which included variable testing, was 69%, according to Jack Ansell, MD, from Lenox Hill Hospital in New York City.

Compared with younger patients (46 to 64 years), older patients (65 to 74 years) had higher a rate of time in target range (67% versus 72%), Ansell reported at the recent American College of Cardiology meeting.

Comparative times in target range from recent large trials evaluating the new oral anticoagulants have included:

Ansell said that home monitoring achieves better outcomes because it's convenient for patients, the test is consistent, and the immediate awareness of test results empowers patients and enhances compliance.

Three-quarters of the patients in the STABLE study were on warfarin for nonvalvular atrial fibrillation, and these patients had better rates in therapeutic range compared with patients with other indications such as valvular disease alone or with atrial fibrillation and venous thromboembolism. Men had a slight edge over women in percent time in target range (72% versus 66%).

Friday, January 27, 2012

Needleless sensor patch aims to replace frequent bloodwork

Now all they have to do is monitor INR readings for those on warfarin and you could have a running tally of it rather than the stupid two week blood draws. And getting cholesterol levels so you could see on a daily basis what your eating habits do.
Does anyone know how to contact Sano to suggest these items? 

Needleless sensor patch aims to replace frequent bloodwork


What if people who have a condition that requires frequent bloodwork could have continuous access to their basic metabolic panel readings without ever having to be poked by a needle?

Early-stage startup Sano Intelligence is taking this concept and running with it, developing a transdermal sensor patch that its founders think could continuously monitor metabolic panels and deliver that data to software platforms or mobile devices.

Founded by Raj Gokal and Ashwin Pushpala — and springboarding off a college project Pushpala worked on — Sano Intelligence is hoping to provide digitalized blood chemistry information to patients and providers through a variety of applications. The original idea was intended for use in diabetes patients, but the founders said they have decided instead to focus on less crowded spaces in healthcare.

Gokal and Pushpala will participate in the Rock Health acceleration program this spring.